in the present study ( including 5 postmenopausal women and 4 normal men ) , no detectable changes were found in plasma levels of da , ne , ep and the da metabolite , 3,4-dihydroxyphenylacetic acid ( dopac ) following lrf ( 100 microgram iv ) administration .
C0028351
ne
C0014563
ep